Using ROCK inhibitors to improve cryopreservation outcomes

We are applying medicinal chemistry (Chemical CryoBiology) approaches to improve the storage of cell based therapies. In the latest work, they apply ROCK (Rho-associated protein kinases) inhibitors to target pathways which lead to cell death after thawing cryopreserved t-cells. This approach is exciting as there is no change required to the cryoprotectants nor the handing process, but just an extra component in the thawing medium, giving up to 20 % more cells: in the context of a cell-based therapy this would be a large increase. 

Read the paper here

Post-thaw application of ROCK-inhibitors increases cryopreserved T-cell yield

Comments

Leave a Reply